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Abstract
Optical coherence tomography (OCT) has gained widespread application for many biomedical 
applications, yet the traditional array of contrast agents used in incoherent imaging modalities do 
not provide contrast in OCT. Owing to the high biocompatibility of iron oxides and noble metals, 
magnetic and plasmonic nanoparticles, respectively, have been developed as OCT contrast agents 
to enable a range of biological and pre-clinical studies. Here we provide a review of these 
developments within the past decade, including an overview of the physical contrast mechanisms 
and classes of OCT system hardware addons needed for magnetic and plasmonic nanoparticle 
contrast. A comparison of the wide variety of nanoparticle systems is also presented, where the 
figures of merit depend strongly upon the choice of biological application.
Index Terms
Contrast agents; optical coherence tomography; plasmonic nanoparticles; superparamagnetic iron 
oxides; magnetomotive
 I. Introduction
OPTICAL coherence tomography (OCT), first reported in 1991 [1], has become widely 
adapted particularly for retinal imaging [2] and other ophthalmic applications [3], with 
emerging applications in coronary artery imaging [4], surgical guidance [5], and endoscopic 
imaging of the gastro-intestinal tract [6, 7] and upper airways [8]. OCT operates on the 
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principle of low-coherence gating to provide a depth-resolved image of light scattering 
within biological tissue [9]. Light scattering, in general, is caused by refractive index 
heterogeneities on the scale of the wavelength of the probing light (λ), which means that 
cells and subcellular objects such as nuclei and mitochondria tend to provide OCT contrast 
[10]. This mechanism of contrast allows one to distinguish different cell layers within the 
human retina [11], sites of atherosclerotic plaque within the coronary artery [12], as well as 
blood flow for angiography [13]. However, it is also somewhat limited for applications such 
as cancer detection, where the speckled features of normal and cancer tissue can appear very 
similar [14].
In order to widen the application space of OCT, there has been much effort to develop 
contrast agents and associated imaging methods [15, 16]. Because OCT only senses 
coherently backscattered light, it cannot detect light from traditional incoherent (fluorescent) 
probes used widely in microscopy. To develop an effective contrast agent probe for OCT, it 
must provide a signal that is distinct from that of the tissue surrounding it. In this paper, we 
discuss two highly successful classes of contrast agents: magnetic contrast agents that, when 
interrogated with a magnetic field, provide a unique motion signal, and plasmon-resonant 
contrast agents that exhibit extremely high optical cross-sections, offering a variety of 
optical effects that can be exploited for sensing within tissue. In many applications such as 
cancer diagnostics, effective targeting of these agents by bioconjugation or the enhanced 
permeability and retention effect is needed, and the reader is directed to reviews for more 
detailed information about targeting moieties [17, 18]. Also, magnetic and plasmonic 
nanoparticles are by no means the only methods for OCT contrast enhancement, and the 
reader is directed to review articles that cover a broader range of development [16, 19, 20].
 II. Magnetomotive OCT: Theory and Practice
The magnetic volume susceptibility at zero magnetic field, χ(B=0), quantifies the rate of 
change in the magnetization of a material as the magnetic flux density, B, is increased. 
Biological tissues are relatively non-magnetic, that is, χ is on the order of −10−5, and is 
dominated by that of water [21]. In comparison, magnetic iron oxides (MIOs) can exhibit χ 
~ 1, or 105 stronger than that of tissue. Thus, χ can provide an effective contrast mechanism 
for magnetic particle imaging. Because OCT is particularly sensitive to motion, with phase-
resolved OCT providing displacement resolution in the picometer range [22], 
magnetomotive OCT (MMOCT) exploits the motion of magnetic nanoparticles induced by 
an applied magnetic field (Fig. 1). This is known as the magnetic gradient force effect:
(1)
where F is the force acting on the MIO with susceptibility χ within its surrounding medium, 
χmed, B is the magnetic flux density, V is the MIO volume, and μ0 is the vacuum 
permeability. Interestingly, the force acting on particles with χ>0 (paramagnetic) always 
points toward the electromagnet, irrespective of the polarity of the B field.
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Magnetic iron oxides are a natural choice as MMOCT contrast agents because iron is 
already metabolized within the human body in large quantities, and iron oxide nanoparticles 
have already been in use as MRI contrast agents with few side effects [23]. There are two 
magnetic crystalline forms of iron oxide: γ-Fe2O3 (maghemite) and Fe3O4 (magnetite), 
which can often be produced by the same synthesis methods and can be difficult to 
distinguish between due to similar X-ray diffraction and magnetic properties [24]. 
Thermodynamically, magnetite slowly oxides to maghemite, then eventually to hematite (α-
Fe2O3, or rust) [25].
Interestingly, the figures of merit for an OCT contrast agent are different than for MRI 
contrast. In MRI, MIOs must be small in order to maximize surface area contact with 
adjacent water molecules, whose magnetic resonance is shifted by the local particle 
magnetization [26]. In OCT, MIOs must maximize their motion via Eqn. (1), which suggests 
a large particle volume, V. However, there are two practical limits to the size of MNPs: a) if 
particles are too large to be administered to the imaging target (e.g., into small capillaries or 
by diffusion through tissue), and b) if particles become significantly ferromagnetic such that 
they irreversibly aggregate under an applied magnetic field. Superparamagnetic iron oxides 
(SPIOs) are typically desired because they maintain strong magnetic susceptibility while 
lacking remanent magnetization. Thus, MMOCT contrast agents tend to have MIO cores 
between ~10-50nm, although larger particle clusters [27] or novel ferrofluid-filled 
microspheres [28] have been developed for certain applications.
Importantly, MIOs are optically absorbing, appearing almost completely black in color. 
Thus, it is not possible to use OCT to directly sense their magnetic gradient-driven motion 
(magnetomotion). It is only in their coupling with adjacent light scattering structures within 
the tissue that they can be detected (Fig. 1). MIOs free in solution (such as a blood vessel) 
will exhibit little OCT motion contrast in comparison to MNPs elastically bound to a target 
within the tissue (such as a targeted cell receptor, or by being internalized into a subcellular 
compartment). Tissue elasticity also provides an important restoring force when the B-field 
is switched off, returning the tissue to its original state of deformation. This allows for the 
application of modulated B-fields to be used to measure several cycles of repeated 
deformation, improving the signal-to-noise ratio (SNR), analogous to lock-in detection.
Despite the ability to attain arbitrarily large SNR with repeated measurements, there is a 
fundamental sensitivity limit to MMOCT given by the ratio of the medium to the particle 
magnetic susceptibility [29]:
(2)
which corresponds to an MIO density on the order of ρ = 8μg/g for a typical MIO. This is 
the MIO concentration where the force from the diamagnetic components of the tissue 
(which push away from the magnet) exactly balance the force on the particles, and there is 
no net motion. Below this limit, the tissue is actually pushed away from the magnet, which 
can be seen particularly if the magnetic field being used is too high. In fact, in [29, 30], it 
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has been shown that there is a decreasing effect of MMOCT contrast with increasing 
magnetic field if the field is above that needed for the MIOs to reach their saturation 
magnetization. This is somewhat counter-intuitive, and can be understood by the fact that the 
diamagnetic tissue magnetization (which is negative) continues to grow with B even after the 
MIO are saturated, eventually cancelling out the MIO magnetization. In the other extreme, if 
the B-field is too low, the MIO motion will be too minute to detect; thus, a sweet spot should 
be determined depending upon the target MIO concentration for the given application and 
phase noise of the OCT system; this sweet spot is typically just a little below the saturation 
field, which for MIOs is ~0.1 T.
The most challenging aspect of an MMOCT system is constructing an appropriate magnetic 
field delivery system. While some researchers have opted for commercially-available 
pointed-core solenoids which provide an extremely strong B field gradient at their tip, this 
requires illuminating the sample from the opposite direction, limiting studies to thin 
samples. In comparison, open-air designs such as in Fig. 1 permit an arbitrarily thick sample 
to be assessed, although do require higher currents to compensate for the lack of a solenoid 
core material, and thus will need to be water-jacketed to dissipate heat. The most expensive 
component is typically the programmable power supply (~100-250W), although a unipolar 
supply can save cost since MNPs will always be pulled in the same direction irrespective of 
polarity (Eq. 1).
Tissue mechanics play an important role in determining the MMOCT sensitivity and 
imaging speed. The displacement is inversely proportional to the tissue elastic modulus, and 
thus stiffer tissues will provide lower MMOCT contrast. At the same time, tissue 
viscoelasticity will slow the response time between the application of the force and the 
resulting displacement, limiting the maximum frequency that the B-field can be modulated 
(in practice, typically <100 Hz). Use of these lower frequencies avoids heating that occurs in 
techniques such as magnetic hyperthermia, where MIOs are modulated typically at >100 
kHz to achieve significant heating effects [31]. In sinusoidally modulated MMOCT where 
the B-field is modulated several cycles per transverse position, this limits the accessible 
imaging acquisition time to several seconds. The new generation of high frame rate OCT 
systems (>100 fps) are currently allowing for MMOCT to be performed by collecting 
several frames (or volumes [32]) per B-field cycle, and thus frame rates nearing video rate 
are now possible.
It should be noted that there are a variety methods for performing MMOCT that are not 
necessarily subject to all of the discussion above, such as a two-coil system for MNP 
contrast in fluids [33], and the use of pulsed, rather than sinusoidal, B-fields [34]. Also, 
related platforms for imaging, including optical Doppler tomography (ODT), optical 
coherence elastography (OCE), and optical coherence microscopy (OCM) have been 
employed with magnetomotive contrast. These will be discussed in more detail in Section V.
 III. Plasmonic Nanoparticle-based contrast with OCT: Theory and Practice
Surface plasmons are a collective excitation of electrons that oscillate across the surface of 
metals. In nanoparticles, these plasmons are confined to a small area and can become 
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resonantly excited by light, either absorbing or re-emitting the light with high efficiency. In 
particular, only the noble metals gold and silver exhibit surface plasmon resonances (SPRs) 
in the visible spectrum, with gold being the only material offering SPRs in the near-infrared 
(NIR) wavelength regime typically used for OCT.
The fact that gold is a noble metal is also fortuitous for biomedical applications; gold is 
chemically inert and has been used as a medicine since ancient times [35], although caution 
should be taken to ensure that the surface charge does not induce cytotoxicity [36].
The SPR property of gold nanoparticles (GNPs) offers a unique opportunity to tailor contrast 
agents for OCT, as summarized conceptually in Fig. 2. For gold nanospheres, the SPR peak 
wavelength shifts gradually from ~535 nm to 635 nm for particles from 20 nm to 140 nm, 
respectively [37]. To access longer wavelengths, shaped particles such as ellipsoids (or, in 
practice, nanorods) are used which split the resonance modes along the principle axes of the 
particle. In the case of gold nanorods, aspect ratios of 2.4 to 5.6 provide longitudinal SPRs 
from ~650 nm to 950 nm, respectively [38].
In addition to nanorods, GNPs with more complex geometries, like nanocages [39], 
nanorings [40] and nanoshells [41], also offer largely tunable spectral ranges. This is useful 
in multichannel measurements as seen with polarization-sensitive OCT [42] and SOCT [43]. 
Furthermore, shifting SPRs toward shorter wavelengths tailors the GNPs for use with 
higher-resolution OCT systems. Conversely, shifting the SPR toward longer wavelengths 
tailors them for OCT systems with larger penetration depths. This makes GNPs attractive for 
use with different systems depending upon the application.
A very important consideration is whether the SPR is predominantly light-absorbing or 
light-scattering in nature. Smaller particles are absorbing, with a transition to scattering-
dominance at ~100 nm in size [44]. Thus, applications such as photothermal OCT (PTOCT), 
which requires high light absorption to generate heat, will tend to prefer smaller GNPs, 
while diffusion OCT (DOCT) exploits dynamic light scattering and prefers larger GNPs. 
Spectroscopic OCT (SOCT) can, in theory, be designed to sense either wavelength-
dependent absorption or scattering, although in practice tends to employ absorption due to 
the already high scattering coefficient of tissue. Importantly, the optical extinction 
coefficient scales with the particle volume, V, in the absorbing regime, and V2 in the 
scattering regime [45], such that increasing particle size can rapidly increase optical 
detection. However, this must be balanced against the needs for smaller particles that can be 
effectively delivered to the biological target of interest.
An important consideration for SOCT is the quality factor (Q) of the SPR, as higher Q will 
provide a stronger wavelength-dependence, as well as the potential for multi-channel 
detection schemes. The Q of gold nanorods in particular has been established to be superior 
to gold spheres [46]. Another property of GNPs is polarization anisotropy, e.g., the ratio of 
the optical polarizability between light that oscillates parallel and perpendicular to the 
geometrical axis of the SPR, which can be exploited for DOCT. The need for polarization 
anisotropy in methods like DOCT, discussed below, also suggests the use of anisotropic 
particles such as gold nanorods.
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There are several notable GNP geometries missing from Fig. 2, including gold nanoshells 
[41] and nanocages [47], which will be discussed in greater detail in Section VI.
 A. Spectroscopic contrast
Spectroscopic OCT (SOCT) was originally developed to assess intrinsic optical properties 
through analysis of the backscattered OCT spectrum [48]. When GNPs are added to tissue, 
they modify the native wavelength-dependent scattering and absorption coefficients (μa(λ) 
and μs(λ), respectively). The resulting OCT signal amplitude is proportional to μs(λ) 
(presumed to scale with the backscattering coefficient, μb) and decays exponentially in 
depth, z, proportional to the total extinction μt = μs + μa [49]. Thus, in SOCT, relative μs can 
be obtained from the overall OCT signal amplitude, and μa is subsequently inferred from a 
differential with respect to z.
Because tissue is highly scattering in the NIR (μa<<μs) [50], most applications of GNPs with 
SOCT have employed absorbing GNPs. If we consider the resulting absorption and 
scattering coefficients in terms of the presence of tissue light scattering structures and 
absorbing GNPs with densities of ρs and ρa, respectively, we can write:
(3)
where εs and εa are the molar extinction coefficients of the tissue and GNPs, respectively. 
Thus, characterization of εs and εa in advance of an imaging experiment can allow for 
estimation of the density of absorbing GNPs, ρa, quantitatively. A least-squares solution for 
this problem exists [51], and models accounting for various noise contributions have been 
described [52]. There are, of course, many other computational methods for detecting 
wavelength-dependent absorbers within tissues, including simpler centroid-shifting methods 
[53], and spectral triangulation [54]. The choice of method should balance the need for 
accuracy and presence of particular sources of noise (such as modulation of wavelength-
dependent scatting in the native tissue) against imaging speed.
Building upon this basic concept, more advanced methods for SOCT-based GNP contrast 
have been developed. For example, differential contrast between OCT images from a non-
overlapping dual-band spectrum has been applied for discrimination between GNPs with 
different SPR wavelengths [55]. In a similar vein, GNPs synthesized with varying SPR 
wavelengths have been suggested for contrast imaging of multiple targeting moieties 
simultaneously [56]. Interestingly, while not demonstrated with SOCT, it may be possible to 
exploit the SPR red-shift that occurs between GNPs as they are brought into close proximity, 
which allows one to sense an activatable event such as binding of multiple GNPs to a single 
location on a cell surface [57].
 B. Photothermal contrast
When absorbing GNPs are used with an SPR in the wavelength band of the OCT light, it is 
often difficult to avoid photothermal heating. Fortunately, the photothermal effect itself can 
be exploited for contrast. As heat dissipates from the GNP into the surrounding aqueous 
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tissue, two effects occur simultaneously: the refractive index (n0) decreases with temperature 
T according to dn/dT (which is on the order of −10−4/°C for water), while the volume 
increases according to the volume expansion coefficient, β (which is on the order of 
2−4×10−4/°C for water). These terms respectively decrease and increase the optical path 
length, with the net path length change being given by the following [58]:
(4)
While these effects this may appear to be small, the cumulative effect of over even L0=10μm 
of path length and a temperature rise of 1°C can give rise to an optical path length difference 
on the order of 3nm, which is within reach of many phase-sensitive OCT systems.
Like MMOCT, PTOCT is a modulated contrast method (dark contrast method), which offers 
greater SNR than methods requiring prior knowledge or reference images of tissue in the 
absence of contrast agents [16]. Typically, PTOCT is performed by modulating a heating 
beam tuned to the GNP SPR but outside the passband of the OCT beam. OCT can then 
monitor the resulting modulation of Δz and employ lock-in detection. The dynamics of heat 
dissipation dictate imaging speed in this method; use of a laser intensity that is too high, or 
modulation without sufficient rest period between heating events results in loss of thermal 
confinement that can lead to creep of the tissue temperature over several modulation cycles 
[58]. Because the temporal response occurs over ~1 ms, modulation speeds on the order of 
10-100s of Hz are typical [58, 59].
More advanced methods have been employed to enhance the PTOCT. Initially demonstrated 
using optical coherence microscopy [60], photothermal optical lock-in OCT (poli-OCT) 
decreases PTOCT acquisition time and eliminates the need for post-processing of images 
using temporal phase data by inducing a phase modulation in the reference arm of the 
interferometer. Setting the integration time of the camera to an integer multiple of the 
frequency shift period results in low-pass filtering of the signal, isolating the signal due to 
photothermal heating and reducing signals from static scatterers to zero [61]. Poli-OCT 
increases image acquisition rates to allow for capturing in vivo time-course dynamics (e.g. 
blood flow and drug delivery).
 C. Diffusion contrast
An emerging form of OCT contrast is exploiting the Brownian diffusion of GNPs as a 
unique, time-dependent signature assessed by dynamic light scattering (DLS) techniques. 
DLS is a technology traditionally used for particle sizing, where the ability to depth-resolve 
DLS signatures in OCT was noted early in the development of OCT [62]. Today, DLS-based 
OCT is most commonly used to quantify aspects of hemodynamics by measuring red blood 
cell diffusion and flow [63]. For the purposes of contrast imaging, DLS of GNPs provides 
some unique opportunities for assessing viscous liquid properties [64] and porous properties 
[65] of tissues. This is because the translational diffusion rate, DT, of spherical particles 
within a viscous medium can be described by the Stokes-Einstein relation:
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(5)
Where η is the medium viscosity, a is the particle radius, and kB is the Boltzmann constant. 
In practice, the diffusion rate can be quantified by computing the temporal autocorrelation, 
Γ, of the OCT signal:
(6)
where q is the scattering vector equal to 2k in the backscattering geometry of OCT. 
Importantly, because GNPs are plasmon-resonant, they provide orders-of-magnitude larger 
optical scattering than non-resonant tissue structures of the same size. Because of the strong 
size-scaling of optical scattering, tissue features that are larger (on the order of λ) will 
dominate the endogenous OCT signal. According to Eq. 5, these larger features will exhibit 
smaller DT, and thus the detection of unusually high DT is a unique signature of GNPs 
within tissue.
The choice of GNPs is therefore dictated by a need for sufficiently large size to provide 
optical scattering, balanced against the diffusivity of GNPs into the tissue. In practice, gold 
nanorods of ~20 nm × 60-80 nm have been found to rapidly homogenize throughout model 
tissue structures, while being sufficiently large for DOCT detection [65]. Interestingly, gold 
nanorods also provide polarization anisotropy (Fig. 2), which provides the ability to measure 
both rotational (DR) and translational (DT) diffusion for further tissue discrimination [64].
The applications of GNP-based DOCT are growing. In tissues, non-adherent GNPs can be 
designed to diffuse through extracellular pores to monitor tissue remodeling processes [65] 
that may provide new insight into cancer growth. In liquids such as mucus, GNPs can 
provide relative measures of hydration [65], providing a metric for assessing respiratory 
diseases like cystic fibrosis. More comprehensive details are provided in Section VI.
 IV. Experimental systems overview
Table 1 provides an overview of many (but not all) magnetic- and plasmonic-based OCT 
contrast systems reported to date, with emphasis on in vivo experiments, novel particle 
geometries, and novel imaging schemes. Within each imaging modality (and within each 
subset of GNP shape), particles are sorted by size from small to large. When possible, a 
particle concentration is given to aid in general comparison between the techniques, 
although the reader should be cautioned that direct comparison of concentrations is not 
always possible due to varying applications and experimental details.
 V. Magnetomotive OCT Experiments
This section is organized as follows. First, the various types of magnetomotive optical 
coherence tomography (MMOCT) systems are described, including phase- vs. amplitude-
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sensitive and sinusoidal vs. pulsed systems. Next, types of magnetic particles that have been 
reported to be used with MMOCT imaging are discussed. Finally, the breadth of potential 
clinical applications for MMOCT is addressed. While this review is intended to represent the 
widest variety of ongoing efforts in this field, for the sake of brevity only a subset of 
publications are able to be addressed.
 A. System Types
MMOCT was first reported by Oldenburg et al in 2004 [66], with follow-up papers in 2005 
[67, 68]. These were obtained using a time-domain OCT system where the B-field was 
modulated for each A-scan; thus, scan times were quite long (1 minute). Because MMOCT 
operates by both optical and mechanical principles, tissue phantoms were prepared to mimic 
the optical and mechanical properties of soft tissue by embedding optically-scattering TiO2 
particles into a silicone matrix. The addition of varying amounts of MIOs into each phantom 
allowed for determination of the MMOCT system sensitivity, which was found to be 220 
μg/mL, establishing a starting point for further improvements [68]. The first in vivo 
MMOCT was obtained in African frog tadpoles (Xenopus laevis) under anesthesia. 
Magnetic particles were consumed by tadpoles via their suction feeders and subsequently 
observed within their digestive tract [68].
This early work was performed using a time-domain OCT that was not phase-sensitive, and 
thus contrast was limited to differences in the OCT signal amplitude. To overcome this 
limitation, a differential-phase OCT system was developed for sensitive displacement 
measurement [69], which was applied to magnetomotive imaging [70]. Results demonstrated 
nanoscale resolution of magnetic particle motion within ex vivo tissues, where the particles 
had accumulated within the in vivo animal models to demonstrate deliverability [70, 71].
The emergence of spectral- or Fourier-domain OCT provided improved imaging times [72, 
73] as well as phase-sensitivity due to the avoidance of moving parts [22]. Crecea et al 
(2007) investigated the spectral-domain amplitude and phase signals from magnetomotion in 
phantoms, and observed free oscillations induced after application of a step-like B-field [74]. 
Further work with phase-resolved magnetomotive OCT by Oldenburg et al (2008) 
demonstrated sensitivity to nanomolar concentrations of magnetic nanoparticles under 
sinusoidal modulation [29]; achieving nanomolar sensitivity marked an important milestone 
for cell-receptor targeted imaging applications.
The application of pulsed magnetic fields has also been explored for MMOCT. By pulsing 
the electromagnet, one can reduce coil heating effects endemic to the higher duty-cycle 
sinusoidal method [34]. Using this technique, phantoms with magnetically-labeled cells at a 
relatively large standoff distance of 30 mm from the coil were imaged [34], and labeled cells 
within 3D constructs have also been contrasted in pulsed MMOCT [75].
While MMOCT is traditionally used to image elastically-bound MIOs within tissue, the 
ability to contrast unbound MIOs in free solution, such as the blood volume, would provide 
new translational opportunities. To address this need, Kim et al (2013) developed the dual-
coil MMOCT system displayed in Fig. 3 [33]. In this configuration, the coils are used to 
apply opposing forces in sequence, in order to initially displace then restore MIOs in 
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solution. Thus, it avoids the need for an intrinsic elastic restoring force to generate a 
modulated displacement signal.
Magnetomotive optical coherence elastography (MMOCE) is a natural extension of 
MMOCT that exploits the dependence of induced tissue vibration on its intrinsic mechanical 
properties. While the vibrational response of tissues to external loading forces was 
demonstrated via OCE [76], the ability to use MIOs to apply those forces internally in 
tissues offers added flexibility and with lower strain rates to avoid nonlinearities. In 2013, 
Crecea et al demonstrated MMOCE by studying free oscillations of ex vivo tissues in 
response to stepped forces, where the vibrational frequency and rise time were 
proportionally and inversely related to the elasticity, respectively [77]. Then, in 2014, Crecea 
et al adapted these methods on an optical coherence microscopy (OCM) setup to investigate 
biomechanical properties on the single-cell scale [78]. Other efforts in MMOCE have 
investigated shear-wave methods commonly used in OCE [79].
The frequency-dependence of tissue mechanical properties can also be exploited by 
interrogating MIOs in tissues at varying frequencies. In 2015, Ahmad et al demonstrate this 
principle in phantoms and tissues, with validation against finite-element modeling [80]. As 
an extension of this, Oldenburg et al (2010) developed a resonant acoustic spectroscopy 
method to measure elasticity of small biosamples with high precision [81]. Interestingly, this 
has found particular application in the assessment of blood clot elasticity [82, 83], which 
may in future work connect with the same group’s efforts in magnetically-loaded platelet 
labeling of blood clots [30].
 B. MIO Particle Sizes and Types
Here we will cover the general classes of MIOs used in MMOCT; for more detailed 
information, the reader is directed to a review on this topic [84]. The choice of magnetic iron 
oxide particle core size and coating for MMOCT should take into consideration the desired 
magnetic properties and targeting moieties. For nanoparticles (<100 nm), several general 
classes of MIOs have been used. One of the most common are dextran-coated MIOs 
produced by a precipitation method that can be performed without special equipment [85]. 
These tend to produce particles in the 10-20 nm size range, while the dextran coating can 
increase their hydrodynamic diameter to 30 nm or more, and have successfully been used in 
several MMOCT studies [82, 86]. An important class of dextran-coated MIOs are MRI 
contrast agents FDA-approved as liver contrast agents; of these, Feridex IV™ has been used 
in several MMOCT studies [30, 70], noting that they are comprised of clusters of ~5 nm 
MIO cores embedded in a larger dextran matrix, with an overall average hydrodynamic 
diameter of 36 nm [23].
To generate nanosized MIOs that have greater size monodispersity, synthesis via thermolysis 
of iron precursors [87]. Commercially available particles prepared in this way are available 
with a variety of coatings (Ocean Nanotech, Inc.); for MMOCT, COOH-coated MIOs have 
been employed with success [81, 88].
The conjugation of antibodies onto MIOs confers them with specificity for specific over-
expressed cell receptors. John et al (2010) conjugated anti-HER2 onto dextran-coated MIO 
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particles, demonstrating specific uptake into tumors via MMOCT in an in vivo rodent model 
of breast cancer; the same particles provided MRI contrast for validation of the particle 
localization within tumors [86].
At the same time, conjugation of fluorescent dyes confers multi-functional (OCT-
fluorescence) imaging capabilities that can aid in validating the biodistribution of MIOs used 
in animal models in vivo. In particular, oil-filled albumin microspheres offer a platform 
particularly amenable to multi-functionalization. Several studies have demonstrated a class 
of such microspheres that are filled with an oil-based ferrofluid containing fluorescent dye, 
while being surface labeled with a peptide to target sites of cancer and atherosclerosis [89, 
90]. Because these protein microspheres are nominally 2-5 μm in size, they are appropriate 
for vascular targets such as atherosclerosis, as well as cancers exhibiting “leaky vasculature” 
where blood pool agents will tend to accumulate [91]. In addition to these customized 
multifunctional particles, MMOCT has also been used with commercially available 
magnetic microbeads that offer fluorescent as well as surface conjugation capabilities [78].
 C. Contrast Imaging Applications
While MMOCT is currently a pre-clinical technology, the breadth of research studies 
implicates a wide variety of future clinical applications. One class of applications lies in 
tracking magnetically-labeled cells, the feasibility of which was initially demonstrated in 3D 
cell culture in early MMOCT work [67]. Because macrophages readily phagocytose 
nanoparticles, MMOCT can be used to track the fate of macrophages in the liver and spleen 
[70], or macrophage-laden sites of vulnerable atherosclerotic plaques [71]. Also, the ability 
to track stem cells is highly sought after for monitoring stem cell therapies; recently, Cimalla 
et al. (2015) demonstrated MMOCT of labeled stem cells in vitro [75], working toward a 
method for monitoring retinal regeneration.
Blood platelets are a powerful tool for functional imaging, as they readily take up foreign 
particles via a mechanisms known as “covercytosis” [92], and play a crucial role in 
hemostasis and thrombosis [93]. Thus, the highly functional nature of platelets can be used 
to target sites of vascular damage where blood clots form. As shown in Fig. 4, MMOCT of 
magnetically-labeled platelets flowed through ex vivo porcine arteries exhibits highly 
specific contrast only to damaged blood vessel walls [30]. In combination with existing 
technologies for cardiovascular imaging [4], MMOCT of labeled platelets, macrophages, or 
functionalized microspheres discussed in the previous subsection, may play a role in 
identifying sites of vulnerable atherosclerotic plaque.
Moving beyond pure imaging applications, there has been recent development in the area of 
theranostics (i.e., simultaneous diagnostics and treatment). Huang et al. (2015) report a 
novel clustered magnetic nanoparticle with both light scattering properties at 860 nm for 
OCT imaging, and absorbing properties at 1064 nm for photothermal therapy [27]. Thus, 
cancer cells were shown to be both imaged and subjected to hyperthermia by the same 
particles. Interestingly, the potential exists to provide heating to tissue directly via magnetic 
fluid hyperthermia by applying a magnetic field modulated in the 100’s of kHz [94], a 
technique that has yet to be explored in conjunction with MMOCT.
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Given the widespread use of OCT in ophthalmic applications, it should be noted that 
MMOCT has also been explored in this area. In 2010, Wang et al. reported the ability to 
contrast magnetic beads in the anterior segment of a mouse eye, which was overlaid on the 
structural OCT image [95]. The same group subsequently developed a SOCT-MMOCT 
platform for detecting cochlin (a precursor of glaucoma) in the trabecular meshowork of 
mice using anti-cochlin labeled magnetic particles [96].
Elastographic applications of magnetomotive imaging via MMOCE are also under 
development. For example, measurements of lung epithelium compliance can aid in tracking 
the progression of bronchiectasis in diseases such as COPD; Chhetri et al. (2010) 
demonstrated MMOCE measurements of in vitro human tracheo-bronchial-epithelial (hBE) 
cells [97]. More recent technological developments by Ahmad et al. (2014) have 
demonstrated promising capabilities for shear-wave based MMOCE in tissues ex vivo [79].
All of these potential applications will be aided by the continually improving acquisition 
rates in OCT technology, which have recently been shown to enable acquisition of entire 
OCT volumes during modulation of the magnetic field for volumetric MMOCT [32].
 VI. Plasmonic Nanoparticle OCT Experiments
Nanoparticles have recently gained popularity for medical imaging and therapeutics due to 
their size and unique optical properties. The size and shape of these nanoparticles govern 
their optical response with the wavelength at plasmon resonance (λSPR) typically occurring 
in the near-infrared (NIR) “biological imaging window.” By altering the size and shape of 
these plasmonic gold nanoparticles (GNPs), λSPR can be shifted to wavelengths from red 
into the NIR, within the detection range of typical OCT systems, making them attractive 
candidates as contrast agents in tissue using current OCT imaging techniques.
The GNPs reviewed here are primarily gold taking the shape of rods, roses, spheres, shells, 
cages, and stars/branches. These shapes offer their own unique optical properties and 
biological characteristics to be discussed. Nanospheres offer a plasmon resonance mode with 
dependence on diameter [98]; cylindrically-shaped nanorods offer two plasmon resonant 
modes (longitudinal and transverse) that can be tuned to the near-IR by adjusting the aspect 
ratio of their length (L) to diameter (d), [99], as described in Section III. Nanoroses are a 
conglomeration of smaller nanospheres (~10nm), that alone, are too small to exhibit a 
plamon resonance, but do as a whole [100]. Nanostars are created from spherical gold seeds 
and have gold branches stemming from the center. The plasmon resonance of these 
structures is governed by the length of these branches and the size of the initial seed, that 
acts to enhance plasmon resonance at the tips [101]. Gold nanocages, created from silver 
nanostructures through a galvanic replacement process, are gold frames taking various 
geometric shapes (e.g. cubes and polyhedrons). The λSPR of these structures, tunable to the 
NIR at exceptionally small sizes, are governed by the outer width (w) and frame thickness 
(t), with absorption dominating for structures <45nm [39]. Nanoshells, created by growing 
gold on a dielectric core, can be tuned with higher precision than other GNPs by altering the 
fabrication materials and size (outer diameter, OD, and inner diameter, ID), [41]. Finally, 
nanorings exhibit a plasmon resonance dependent upon the ratio of the outer diameter to the 
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ring thickness. Nanorings can exhibit redshifts into the NIR as large as 100’s of nm by 
making small changes to the ring thickness, while keeping the overall outer diameter 
constant [40].
The properties of these GNPs offer unique contributions that lend to a wide variety of 
biomedical imaging, diagnostic, and therapeutic applications. Below, we review this variety 
of applications using spectroscopic, photothermal, and diffusion OCT (SOCT, PTOCT, and 
DOCT).
 A. Spectroscopic systems
In SOCT, localized spectral measurements are taken within the OCT image. However, the 
strongly modulated spectrum of tissue light scattering, and the fundamental trade-off 
between spatial and spectral resolution makes SOCT challenging for biomedical 
applications. Several techniques have been described to overcome these challenges, 
including differential absorption [102], spectral fractionation [103], and spectral 
triangulation [104]. These methods require scatterers with known spectral characteristics 
that can be tuned with respect to the OCT signal bandwidth (ΔλOCT), for which GNPs are 
well suited. Before discussing the application of GNPs for spectroscopic (wavelength-
dependent) contrast, it is prudent to first mention work done to enhance intensity-based 
contrast (i.e., changes to the overall OCT signal intensity) through exploitation of GNP’s 
unique absorption and scattering characteristics.
Because GNPs strongly absorb/scatter light at tunable wavelengths, OCT intensity imaging 
can be enhanced for better contrast and penetration in tissue. Oldenburg et al. first described 
gold nanorods as contrast agents in OCT using their low backscattering albedo compared to 
that of tissue [44]. Around the same time, Chen et al. investigated small nanocages (<40 nm) 
as absorptive contrast agents in OCT, with implications for cell targeting in both diagnostics 
and therapeutics. These studies paved the way for contrast enhancement using highly 
absorbing/scattering GNPs. For example, nanoshells have been used in imaging and ablating 
tumors in mice [105] and contrasting in vivo on pig skin [106] and rabbit skin [107]; 
nanorods have been used to enhance contrast in tumors [108] and in vivo mouse eyes [109]; 
nanostars have been used in cell imaging [110]; and nanoparticle accumulation in tumors 
has been monitored [111].
Building upon these works, investigators have derived new methods and applications of 
OCT intensity contrast. For example, Tseng et al. showed that strong absorption by gold 
nanorings at λOCT could heat pig adipose during imaging, changing the tissue properties and 
thereby enhancing contrast [112]. Xi et al. introduced a new method of characterizing 
nanoparticle properties by cross-referencing with tissue void of nanoparticles [113]. Doppler 
OCT has been enhanced using gold nanorods by Wang et al. for imaging ocular flow [114]. 
Sirotkina et al. found that OCT intensity enhancement could be used to estimate gold 
nanoparticle accumulation in tumors for guided laser hyperthermia [115]. Later, Couglin et 
al. showed that by conjugating gold nanoshells with Gadolinium, contrast could be enhanced 
for MRI and X-Ray, in addition to OCT, for multimodal diagnostics and therapeutics in 
cancer [116]. Lastly, the growth of nanocubes has been studied by Ponce de Leon et al., by 
monitoring enhanced contrast during the nanocube growth [117].
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While extensive work has been done studying intensity contrast enhancements using GNPs, 
few have exploited their wavelength-dependent properties to provide more specific contrast 
against the tissue background. Cang et al. introduced gold nanocages as contrast agents in 
spectroscopic OCT [47]. The strong absorption at λSPR for the 35 nm cages allowed for 
stronger contrast within ΔλOCT, providing contrast via both the spectral content and change 
in overall OCT intensity (shown in Fig. 5). Oldenburg et al. extended this technique, first 
into interlipid phantoms [118], and then into ex vivo tissue using gold nanorods [119]. The 
authors showed that relative nanorod density was evident against strong scattering in human 
carcinoma breast tissue, lending toward an in vivo human tumor contrast agent.
Other methods of spectroscopic OCT have recently been employed. Wei et al. demonstrated 
the use of GNRs with different aspect ratios, thus different λSPR, as a method of differential 
absorption OCT, with implications in molecular imaging and contrasting highly scattering 
tissues [102]. Expanding on differential absorption contrast techniques, Rawashdeh et al. 
showed that a dual-bandwidth OCT system was capable of providing spectroscopic contrast 
using different sizes of nanorods tuned to different λSPR [43]. This technique was 
demonstrated in agar/TiO2 phantoms and ex vivo muscle tissue. Similarly, Jia et al. employ a 
new method of spectral fractionalization by dividing the OCT bandwidth into sub-bands, 
providing OCT contrast by comparing the ratio of short to long wavelengths [103]. They 
demonstrate this method in an interlipid tissue phantom and in vitro using a 3D cell culture, 
moving toward imaging the human retina in vivo.
 B. Photothermal
PTOCT provides enhanced tissue contrast by exploiting the photothermal properties of 
GNPs heated at λSPR. This method is especially attractive for cancer applications due to its 
ability to both detect GNPs in tissue and induce a therapeutic response by tissue through 
GNP heating. The following describes work that has been done using GNP contrast 
enhancement with PTOCT.
This was first demonstrated nearly simultaneously by two research groups. Adler et al. 
introduced 120 nm gold nanoshells for contrast enhancement using photothermal OCT, 
demonstrated in tissue phantoms [58]. Skala et al. applied PTOCT in 2D and 3D cell 
cultures using 60 nm gold nanospheres [59]. Zhou et al. demonstrated the use of nanoshells 
in ex vivo breast tissue, and showed that oversampling improves SNR [120]. More complex 
nanoparticle constructs were introduced by Paranjape et al., who used gold nanoroses to 
detect macrophages [121]. Small nanospheres were clustered together, forming roses, to 
exhibit strong absorption at the tuned λSPR, making them attractive candidates for 
photothermal OCT. The tunability of these clusters post-manufacturing gives them the 
unique ability to sense different types of environments. These “smart” particles can be 
engineered to cluster under specific conditions, such that λSPR shifts into the photothermal 
imaging window at discrete clustering states. Xiao et al. demonstrated this using pH-
activated aggregation for cell imaging [122]. Chi et al. took advantage of the ability for 
nanorings to be tuned far into the infrared by using two OCT systems, one with λOCT 
matching λSPR, and the other with λOCT outside the peak of λSPR [123]. The authors found 
that PTOCT could disambiguate the source of scattering seen in conventional OCT images. 
Oldenburg et al. Page 14
IEEE J Sel Top Quantum Electron. Author manuscript; available in PMC 2017 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Furthermore, they found that when using PTOCT with λOCT= λSPR, only tissue scattering 
was seen with OCT, with nanorings being detected with PTOCT.
Recently, new techniques have been employed to enhance PTOCT abilities using GNPs. 
Nahas, et al. combined full-field OCT (FFOCT), which collects high resolution (~1 μm) en 
face 2D images, with PTOCT techniques using nanospheres [124]. Because FFOCT only 
images the surface of the tissue, thermal responses of the tissue to modulated energy pulses 
were delayed with rates dependent upon particle depth. The authors were able to extract the 
depth location of nanospheres in tissue based on these response delay times to triangulate 
the location of nanospheres in 3D tissue. This technique allows the combined benefit of high 
resolution FFOCT and cell targeting with PTOCT. In addition to resolution enhancement, 
speed of PTOCT has been improved using optical lock-in techniques (coined poli-OCT), 
previously described by Pache et al. for optical coherence microscopy [60]. Tucker-Schwartz 
et al. employed these methods to improve imaging speed in an in vivo mouse ear [61]. Here, 
they show that poli-OCT can disambiguate motion due to blood flow against the PTOCT 
signal (Fig. 6).
 C. Diffusion
As technology progresses with OCT, new methods are possible owing to increased imaging 
rates and resolution. Particles exhibit a natural Brownian motion that can be measured using 
dynamic light scattering (DLS) within a coherence volume [62]. The rapid collection rates 
and coherence gating techniques used in spectral-domain OCT (SD-OCT) makes it an 
attractive candidate for measuring these movements using DLS, as has previously been 
shown [125]. Furthermore, SD-OCT with polarization sensitivity (PS-OCT) allows for 
discrimination between optically anisotropic scatterers (like nanorods) and isotropic 
particles (like cells). The small size and strong scattering of GNPs make them excellent 
candidates for diffusion OCT (DOCT).
Diffusion of gold nanorings was first tracked by Lee, et al. The authors were able to contrast 
diffusion of these nanorings against native tissue by mapping OCT speckle variance within 
the image to track the diffusion of these particles over time [126]. Exploiting the optical 
anisotropy of nanorods, Mehta and Chen used simulations to show enhanced polarization 
sensitive contrast using a chiral nanostructure constructed from two nanorods [127]. Chhetri 
et al. used this polarization sensitivity to monitor rotational motion of rods, whose 
movement about the axis results in polarization dependent intensity fluctuations. Using DLS 
theory, the authors showed the rotational diffusion of gold nanorods could accurately predict 
the viscosity of a Newtonian diffusion in liquids [64]. Oldenburg et al. then used DOCT to 
discriminate between tissue and cells using the decorrelation time of speckle fluctuations 
(A) in addition to the cross-polarized intensity signals (PS) that are only evident from 
nanorod scatters [42]. The authors found that these properties, along with cellular motility 
measurements (M), created unique MAPS signatures by which cells and tissue could be 
clearly contrasted, with applications ranging from functional drug delivery to quantification 
of tissue properties. Fig. 7 shows an example of this MAPS (motility-amplitude-
polarization-sensitive) signature in artificial tissue seeded with mammary epithelial cells. 
This group later extended DOCT measurements to quantify non-Newtonian fluids 
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(polyethylene glycol) which led to quantification of polymeric tissues like mucus and 
artificial tissue. Chhetri et al. showed that nanorod diffusion could predict the diseased state 
of mucus, with implications in treating respiratory diseases like Cystic Fibrosis, and the 
extracellular matrix, with implications for monitoring the diseased state of tissue during 
tumorigenesis [65].
 VII. Conclusion
The use of magnetic iron oxide and plasmonic gold nanoparticles offer many advantages for 
OCT contrast, in addition to excellent biocompatibility. The choice of a particular particle 
and contrast method should be considered relative to the needed application, ranging from 
molecular contrast imaging of cell surface receptors, to the quantification of extracellular 
nanoporosity. All of the above methods offer sufficiently high imaging speeds and safety to 
be used in vivo, which may lead to new clinical applications for diagnostics, guidance, and 
treatment monitoring.
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Fig. 1. 
Concept diagram of sinusoidal MMOCT. Tissue containing MNPs (black dots) is placed in 
the fringe field (blue lines) of a solenoid, while the OCT imaging beam scans through its 
bore. A square-root sinusoidal voltage applied to the solenoid produces a pure sinusoidal 
force on MNPs directed along the field gradient. OCT detects the resulting axially-directed 
motion (z) of light-scattering structures within the tissue that are mechanically coupled to 
the MNP motion.
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Fig. 2. 
General trends in the optical properties of gold nanospheres and prolate ellipsoids as a 
function of size and aspect ratio, respectively. The various contrast methods (SOCT, PTOCT, 
and DOCT) each have different figures of merit that dictate different particle sizes and 
shapes.
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Fig. 3. 
he schematic and output of a dual-coil magnetomotive OCT setup employing magnetically 
labeled microspheres (MSs) in a flow phantom containing phosphate-buffered saline (PBS). 
(Reprinted with permission from [33]).
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Fig. 4. 
Sample B-mode images of ex vivo porcine arteries following exposure in a flow chamber to 
SPIO-RL platelets. (a) OCT image of control artery (b) OCT image of damaged artery (c) 
magnetomotive OCT image of control artery (d) magnetomotive OCT image of damaged 
artery. Note that each artery is longitudinally cut with the luminal wall facing upward. Scale 
bar: 0.5 mm (Reprinted with permission from [30]).
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Fig. 5. 
Spectroscopic OCT images of TiO2 gelatin phantom, with right side doped with 35 nm 
nanocages. (a) Standard OCT showing decreasing signal in location with absorbing 
nanocages. (b) Spectroscopic OCT showing changes in scattered spectra. (c) Hue-
Saturation-Value (HSV) image of the same cross section with hue representing centroid 
wavelength, and saturation/value representing OCT intensity. (d) Plot of intensity versus 
depth versus wavelength. (Reprinted with permission from [47]).
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Fig. 6. 
Matrigel containing gold nanorods injected into an in vivo mouse ear showing blood flow 
via speckle variance (red) and nanorods via PTOCT (green). (a) Blood flow without 
nanorods and with modulating laser off. (b) Blood flow without nanorods and with 
modulating laser on. (c) Blood flow with nanorods and the modulating laser off. (d) Blood 
flow with nanorods and the modulating laser on. (Reprinted with permission from [61]).
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Fig. 7. 
MAPS signature in a cell culture containing mammary epithelial cells where DOCT was 
used to enhance contrast of tissue containing gold nanorods against cells void of nanorods. 
(Reprinted with permission from [42]).
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